Author: Brian Bollinger, Simply Safe Dividends

In short, investors need to account for the company’s uninspiring growth outlook and the potential need for another big acquisition to improve its growth trajectory. With other pharma stocks offering similar yields, clearer growth potential, and more diversified drug portfolios, investors interested in this space may consider looking elsewhere.

Each stock on this list appears to have a safe dividend, backed by a stable business model and healthy payout ratio, a strong balance sheet, and below average stock price volatility. Simply put, these 10 dividend aristocrats can help you sleep better at night during the next economic and market downturn, whenever that proves to be.

It has the potential to be a decent high-yield investment for a diversified retirement portfolio.

Few companies have maintained as strong of a dividend growth track record as this one. In fact, it’s arguably the most reliable monthly dividend stock in the market for conservative investors seeking a blend of current income and moderate but dependable payout growth.

It’s enjoyed excellent growth in its portfolio, investment income, and distributable net investment income (which funds the dividend) in recent years.